Episode 48

Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay

Featuring an interview with Dr Rana R McKay, including the following topics:

  • Prostate Cancer Working Group (PCWG4) revised terminology (0:00)
  • Cardiovascular effects associated with GnRH agonists versus antagonists; mechanism of action (2:17)
  • Combination therapy using relugolix; factors affecting persistence and adherence to GnRH agents (12:06)
  • Takeaways from the Phase III EMBARK study (19:36)
  • Use of CAR (chimeric antigen receptor) T-cell therapy and T-cell engagers (27:20)
  • Potential role of circulating tumor DNA minimal residual disease testing; use of olaparib/radium-223 (29:24)

CME information and select publications

All Episodes Previous Episode

About the Podcast

Show artwork for Prostate Cancer Update
Prostate Cancer Update
Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care.

Listen for free